Healthcare & Life Sciences
Taysha Gene Therapies
United Statestaysha.com
Taysha Gene Therapies is a Healthcare & Life Sciences startup based in the United States, most recent round Pre-IPO.
pre-ipo
pre-ipo
Stage
About Taysha Gene Therapies
Based in the United States, Taysha Gene Therapies is a startup. Its most recent tracked round is Pre-IPO. Brouky classifies it under Healthcare & Life Sciences.
Taysha Gene Therapies is a clinical-stage company developing AAV-based gene therapies targeting monogenic central nervous system diseases, with lead candidates for GM2 gangliosidosis, Rett syndrome, and CLN1.
Explore Taysha Gene Therapies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.